Phil Nadeau
Stock Analyst at TD Cowen
(3.68)
# 753
Out of 4,479 analysts
15
Total ratings
56.25%
Success rate
48.34%
Average return
Main Sectors:
Top Industries:
7 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintains: Outperform | $360 → $370 | $473.78 | -21.90% | 6 | Aug 2, 2023 | |
| ELVN Enliven Therapeutics | Initiates: Outperform | n/a | $21.70 | - | 1 | Mar 3, 2023 | |
| BIIB Biogen | Maintains: Outperform | $300 → $315 | $228.82 | +37.66% | 4 | Feb 16, 2023 | |
| MLTX MoonLake Immunotherapeutics | Initiates: Outperform | n/a | $40.15 | - | 1 | Jul 7, 2022 | |
| AURA Aura Biosciences | Initiates: Outperform | n/a | $7.15 | - | 1 | Nov 23, 2021 | |
| ANNX Annexon | Initiates: Outperform | n/a | $4.57 | - | 1 | Aug 18, 2020 | |
| RYTM Rhythm Pharmaceuticals | Initiates: Outperform | n/a | $42.34 | - | 1 | Oct 30, 2017 |
Vertex Pharmaceuticals
Aug 2, 2023
Maintains: Outperform
Price Target: $360 → $370
Current: $473.78
Upside: -21.90%
Enliven Therapeutics
Mar 3, 2023
Initiates: Outperform
Price Target: n/a
Current: $21.70
Upside: -
Biogen
Feb 16, 2023
Maintains: Outperform
Price Target: $300 → $315
Current: $228.82
Upside: +37.66%
MoonLake Immunotherapeutics
Jul 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $40.15
Upside: -
Aura Biosciences
Nov 23, 2021
Initiates: Outperform
Price Target: n/a
Current: $7.15
Upside: -
Annexon
Aug 18, 2020
Initiates: Outperform
Price Target: n/a
Current: $4.57
Upside: -
Rhythm Pharmaceuticals
Oct 30, 2017
Initiates: Outperform
Price Target: n/a
Current: $42.34
Upside: -